Trichomonas vaginalis Donne-质粒载体-ATCC-DSM-CCUG-泰斯拓生物

你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: 0574-87917803
Trichomonas vaginalis Donne
Trichomonas vaginalis Donne
规格:
货期:
编号:TS138012
品牌:Testobio
产品名称: Trichomonas vaginalis Donne
商品货号: TS138012
Strain Designations: CDC 085
Application:
Sexually Transmitted Disease Research
Biosafety Level: 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Isolation: Human, Columbus, OH, 1980
Product Format: frozen
Storage Conditions: Frozen Cultures:
-70°C for 1 week; liquid N2 vapor for long term storage

Freeze-dried Cultures:
2-8°C

Live Cultures:
See Protocols section for handling information
Type Strain: no
Antibiotic Resistance:
metronidazole-resistant
Comments:
Metronidazole-resistant
Antioxidant defences
Phospholipid metabolism
Medium: ATCC® Medium 2154: LYI Entamoeba medium
ATCC® Medium 361: Modified TYM basal medium (ATCC medium 358) with pH adjusted to 6.0 and 0.2-0.5 ml of heat-inactivated horse serum added per tube before use
Growth Conditions: Temperature: 35°C
Atmosphere:xa0Anaerobic
Culture System: Axenic; pH 6.0
Cryopreservation: Harvest and Preservation
  1. Harvest cells from a culture that is at or near peak density by centrifugation at 800 x g for 5 min. The cells grown in a medium containing agar are concentrated by centrifugation, a solid pellet does not form. The soft pellet is resuspended to desired cell concentration with agar-free supernatant.
  2. Adjust the concentration of cells to 2 x 106xa0 to xa02 x 107/mL in fresh medium.
  3. While cells are centrifuging prepare a 10% (v/v) solution of sterile DMSO in fresh medium.
    1. Add 1.0 mL of DMSO to an ice cold 20 x 150 mm screw-capped test tube.
    2. Place the tube on ice and allow the DMSO to solidify (~5 min) and then add 9.0 mL of ice cold medium.
    3. Invert several times to dissolve the DMSO.
    4. Allow to warm to room temperature.
  4. Mix the cell preparation and the DMSO in equal portions. Thus, the final concentration will be 106 to xa0107 cells/mL and 5% (v/v) DMSO. The time from the mixing of the cell preparation and DMSO stock solution before the freezing process is begun should no less than 15 min and no longer than 30 min.
  5. Dispense in 0.5 mL aliquots into 1.0 mL toxa02.0 mL sterile plastic screw-capped cryules (special plastic vials for cryopreservation).
  6. Place the vials in a controlled rate freezing unit.xa0 From room temperature cool at -1°C/min to -40°C.xa0 If the freezing unit can compensate for the heat of fusion, maintain rate atxa0-1°C/min through the heat of fusion.xa0 At -40°C plunge into liquid nitrogen. Alternatively, place the vials in a Nalgene 1°C freezing apparatus.xa0 Place the apparatus at -80°C for 1.5 to 2 hours and then plunge ampules into liquid nitrogen.xa0 (The cooling rate in this apparatus is approximatelyxa0-1°C/min.) xa0
  7. The frozen preparations should be stored in either the vapor or liquid phase of a nitrogen refrigerator. Frozen preparations stored below -130°C are stabile indefinitely. Those stored at temperatures above -130°C are progressively less stabile as the storage temperature is elevated. Vials should not be stored above -55°C.
  8. To establish a culture from the frozen state place an ampule in a water bath set at 35°C. Immerse the vial just to a level just above the surface of the frozen material. Do not agitate the vial.
  9. Immediately after thawing, do not leave in the water bath, aseptically remove the contents of the ampule and inoculate a 16 x 125 mm screw-capped test tube containing either 9 mL of ATCC medium 361 (completed with serum) or 13 mL ATCC Medium 2154 adjusted to pH 6.0.
  10. Incubate the culture at 35°C with the cap screwed on tightly (tube should be vertical for medium 361 or on a 15° horizontal slant for medium 2154).
Name of Depositor: M Muller
Chain of Custody:
ATCC <-- M Muller <-- J.G. Lossick
Year of Origin: 1980
References:

Adagu IS, et al. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. 49: 103-111, 2002. PubMed: 11751773

Beach DH, et al. Phospholipid metabolism of cultured Trichomonas vaginalis and Tritrichomonas foetus. Mol. Biochem. Parasitol. 44: 97-108, 1991. PubMed: 2011157

Bouma MJ, et al. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus. J. Antimicrob. Chemother. 42: 817-820, 1998. PubMed: 10052908

Ellis JE, et al. Antioxidant defences in the microaerophilic protozoan Trichomonas vaginalis: comparison of metronidazole-resistant and sensitive strains. Microbiology 140: 2489-2494, 1994. PubMed: 7952198

Lloyd D, Pedersen JZ. Metronidazole radical anion generation in vivo in Trichomonas vaginalis: oxygen quenching is enhanced in a drug-resistant strain. J. Gen. Microbiol. 131: 87-92, 1985. PubMed: 2985740

Meri T, et al. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations. J. Clin. Microbiol. 38: 763-767, 2000. PubMed: 10655382

Muller M, et al. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex. Transm. Dis. 15: 17-24, 1988. PubMed: 3258675

Muller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery 93: 165-171, 1983. PubMed: 6849201

Vanacova S, et al. Characterization of Trichomonad species and strains by PCR fingerprinting. J. Eukaryot. Microbiol. 44: 545-552, 1997. PubMed: 9435127

首页 > 产品中心 > 微生物培养 > 菌株 > null > Trichomonas vaginalis Donne

Trichomonas vaginalis Donne

  • 货号: TS138012
  • 好评
有货
  • 品牌 : TESTOBIO
产品名称: Trichomonas vaginalis Donne
商品货号: TS138012
Strain Designations: CDC 085
Application:
Sexually Transmitted Disease Research
Biosafety Level: 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Isolation: Human, Columbus, OH, 1980
Product Format: frozen
Storage Conditions: Frozen Cultures:
-70°C for 1 week; liquid N2 vapor for long term storage

Freeze-dried Cultures:
2-8°C

Live Cultures:
See Protocols section for handling information
Type Strain: no
Antibiotic Resistance:
metronidazole-resistant
Comments:
Metronidazole-resistant
Antioxidant defences
Phospholipid metabolism
Medium: ATCC® Medium 2154: LYI Entamoeba medium
ATCC® Medium 361: Modified TYM basal medium (ATCC medium 358) with pH adjusted to 6.0 and 0.2-0.5 ml of heat-inactivated horse serum added per tube before use
Growth Conditions: Temperature: 35°C
Atmosphere:xa0Anaerobic
Culture System: Axenic; pH 6.0
Cryopreservation: Harvest and Preservation
  1. Harvest cells from a culture that is at or near peak density by centrifugation at 800 x g for 5 min. The cells grown in a medium containing agar are concentrated by centrifugation, a solid pellet does not form. The soft pellet is resuspended to desired cell concentration with agar-free supernatant.
  2. Adjust the concentration of cells to 2 x 106xa0 to xa02 x 107/mL in fresh medium.
  3. While cells are centrifuging prepare a 10% (v/v) solution of sterile DMSO in fresh medium.
    1. Add 1.0 mL of DMSO to an ice cold 20 x 150 mm screw-capped test tube.
    2. Place the tube on ice and allow the DMSO to solidify (~5 min) and then add 9.0 mL of ice cold medium.
    3. Invert several times to dissolve the DMSO.
    4. Allow to warm to room temperature.
  4. Mix the cell preparation and the DMSO in equal portions. Thus, the final concentration will be 106 to xa0107 cells/mL and 5% (v/v) DMSO. The time from the mixing of the cell preparation and DMSO stock solution before the freezing process is begun should no less than 15 min and no longer than 30 min.
  5. Dispense in 0.5 mL aliquots into 1.0 mL toxa02.0 mL sterile plastic screw-capped cryules (special plastic vials for cryopreservation).
  6. Place the vials in a controlled rate freezing unit.xa0 From room temperature cool at -1°C/min to -40°C.xa0 If the freezing unit can compensate for the heat of fusion, maintain rate atxa0-1°C/min through the heat of fusion.xa0 At -40°C plunge into liquid nitrogen. Alternatively, place the vials in a Nalgene 1°C freezing apparatus.xa0 Place the apparatus at -80°C for 1.5 to 2 hours and then plunge ampules into liquid nitrogen.xa0 (The cooling rate in this apparatus is approximatelyxa0-1°C/min.) xa0
  7. The frozen preparations should be stored in either the vapor or liquid phase of a nitrogen refrigerator. Frozen preparations stored below -130°C are stabile indefinitely. Those stored at temperatures above -130°C are progressively less stabile as the storage temperature is elevated. Vials should not be stored above -55°C.
  8. To establish a culture from the frozen state place an ampule in a water bath set at 35°C. Immerse the vial just to a level just above the surface of the frozen material. Do not agitate the vial.
  9. Immediately after thawing, do not leave in the water bath, aseptically remove the contents of the ampule and inoculate a 16 x 125 mm screw-capped test tube containing either 9 mL of ATCC medium 361 (completed with serum) or 13 mL ATCC Medium 2154 adjusted to pH 6.0.
  10. Incubate the culture at 35°C with the cap screwed on tightly (tube should be vertical for medium 361 or on a 15° horizontal slant for medium 2154).
Name of Depositor: M Muller
Chain of Custody:
ATCC <-- M Muller <-- J.G. Lossick
Year of Origin: 1980
References:

Adagu IS, et al. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. 49: 103-111, 2002. PubMed: 11751773

Beach DH, et al. Phospholipid metabolism of cultured Trichomonas vaginalis and Tritrichomonas foetus. Mol. Biochem. Parasitol. 44: 97-108, 1991. PubMed: 2011157

Bouma MJ, et al. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus. J. Antimicrob. Chemother. 42: 817-820, 1998. PubMed: 10052908

Ellis JE, et al. Antioxidant defences in the microaerophilic protozoan Trichomonas vaginalis: comparison of metronidazole-resistant and sensitive strains. Microbiology 140: 2489-2494, 1994. PubMed: 7952198

Lloyd D, Pedersen JZ. Metronidazole radical anion generation in vivo in Trichomonas vaginalis: oxygen quenching is enhanced in a drug-resistant strain. J. Gen. Microbiol. 131: 87-92, 1985. PubMed: 2985740

Meri T, et al. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations. J. Clin. Microbiol. 38: 763-767, 2000. PubMed: 10655382

Muller M, et al. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex. Transm. Dis. 15: 17-24, 1988. PubMed: 3258675

Muller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery 93: 165-171, 1983. PubMed: 6849201

Vanacova S, et al. Characterization of Trichomonad species and strains by PCR fingerprinting. J. Eukaryot. Microbiol. 44: 545-552, 1997. PubMed: 9435127

合作单位: